Stem Cell Banking
Reserving biological inputs for future regenerative care.
The premise behind stem-cell banking is straightforward: adult stem cells — mesenchymal stem cells (MSCs) from adipose tissue or bone marrow, hematopoietic stem cells from peripheral blood, dental pulp cells from extracted teeth — vary in number, vitality, and regenerative potential across a lifetime. They are more abundant and more potent at age 30 than at age 60. Banking refers to harvesting a sample at a relatively young or healthy state, expanding it under controlled conditions, and cryopreserving it in liquid-nitrogen storage for potential future autologous applications. The research conversation is about which cell types are worth banking, how to source them ethically and safely, how to ensure long-term viability through cryopreservation, and which clinical applications the field will mature to in the coming decades. The MMC Anti-Aging Research Institute follows this conversation closely and contributes through academic partnership with Dr. Lorena Braid (SFU; Chair, Canadian MSC Research Society).
Not yet within Canadian clinical offerings.
Stem-cell banking as a commercial clinical service is highly regulated in Canada. Cell therapy products fall under Health Canada's Schedule D and require either an approved Notice of Compliance for a specific indication or operation under a clinical trial framework with Research Ethics Board oversight. There is no current MMC commercial banking offering, and we do not encourage members to pursue offshore alternatives that bypass Canadian regulatory protections. The MMC Anti-Aging Research Institute participates in this direction strictly inside the academic research framework with SFU and Shanghai Xinuo Shenzhou (founded December 2021). If the regulatory environment evolves and a compliant clinical pathway opens, the Club will inform members through documented channels. The service, when it exists, will be operated independently by appropriately licensed partner organizations.
Briefings, newsletters, and academic visibility.
What MMC offers Longevity Club members today is visibility into one of the most consequential regenerative-medicine conversations of the next two decades. Members receive quarterly research briefings summarizing global progress in mesenchymal stem-cell biology, induced-pluripotent-stem-cell therapies, hematopoietic banking, and adjacent fields. Periodic in-person seminars with Dr. Lorena Braid and other SFU and UBC faculty are open to members on a rotating basis. Members with specific clinical questions — for example, evaluating offshore banking services they may have been approached about — can request a 1:1 evidence review with Dr. Jiang's team. This is academic visibility and consultative support, not a clinical service, and we are deliberate about that distinction.
- 01
Academic Partnership
MMC Anti-Aging Research Institute × SFU (Dr. Lorena Braid; Chair, Canadian MSC Research Society).
- 02
Canada–China Bridge
Shanghai Xinuo Shenzhou (founded December 2021) academic partner.
- 03
Cell Sources Under Study
Adipose, bone marrow, peripheral blood, dental pulp — research-stage exploration only.
- 04
Cryopreservation Research
Cryoprotectants, freezing protocols, and long-term liquid-nitrogen viability.
- 05
Ethics Review
Any cohort inclusion requires Research Ethics Board approval.
- 06
Member Briefings
Quarterly research newsletters, periodic SFU faculty seminars.
- 07
Consultative Support
1:1 evidence review with Dr. Jiang's team for members evaluating offshore options.
- 08
Research Boundary
Not a clinical offering today; no medical commitment to members.
Frequently Asked
Can I bank my stem cells through MMC today?
No. There is no current MMC commercial stem-cell banking offering. This is a research direction we participate in academically, and Canadian regulatory rules do not currently permit commercial autologous stem-cell banking outside of approved clinical trial frameworks. We do not encourage offshore banking alternatives that bypass Canadian regulatory protections.
What if I have already banked my cells offshore?
We can offer a 1:1 consultative review with Dr. Jiang's team to evaluate the credentials of the storage facility, the documentation of cell viability, the realistic clinical applicability of the stored material, and what protections you do or do not have. We do not assist with retrieval, transfer, or clinical use of cells stored outside compliant Canadian frameworks.
When will stem-cell banking be available clinically?
We do not know — and any clinic that gives you a confident date is overpromising. The regulatory and clinical pathway is evolving slowly. We will inform Longevity Club members through documented channels if and when a compliant Canadian pathway opens.